Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Certain long non-coding RNAs are important for controlling hair growth cycles in sheep.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Cancer survivors need better skin care to improve their quality of life.

Dr. Zitelli emphasized that "Mohs surgery" should only be called that when one doctor does both the surgery and pathology.

Collagen-heparin-FGF2-VEGF scaffolds can improve skin healing.

The study showed that hair follicle stem cells can maintain and organize themselves in a lab setting, keeping their ability to renew and form hair and skin.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

The study identified key genes and pathways that influence goat wool quality and growth.

Minoxidil may help reduce aging effects in brain cells.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.